
Resvom 5mg Tablet
Marketer
Unimarck Healthcare Ltd
Salt Composition
Prochlorperazine (5mg)
Overview Resvom 5mg Tablet
Vertigo, nausea, vomiting, and migraine headaches stemming from Meniere's disease or other inner ear issues are treated with the 5mg Resvom tablet. This medication also provides short-term relief from non-psychotic anxiety. Dosage and treatment duration for Resvom 5mg are determined by your physician and should be taken post-meal. Continue use as directed; long-term therapy is not advised. Sedation is a common side effect, so avoid operating machinery or driving. Alcohol consumption should be avoided due to increased drowsiness. Orthostatic hypotension and blurred vision may occur temporarily. Report any concerns to your doctor immediately. Prior to commencing treatment, disclose any pre-existing conditions including jaundice, epilepsy, myasthenia gravis, glaucoma, liver, kidney, or heart disease, and a complete list of all other medications currently in use, as interactions may occur. Consult your doctor before taking Resvom if you are pregnant or breastfeeding.
Primary Ingredients of Resvom 5mg Tablet
No text provided to rephrase.
Uses of Resvom 5mg Tablet
Managing Vomiting | Migraine Relief | Short-Term Anxiety Management | Vertigo Therapy | Nausea Control
Major Benefits of Resvom 5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Resvom 5mg Tablets. Ingest each tablet whole; do not crush, chew, or divide it. Take with food.
Common Side effects of Resvom 5mg Tablet:
- Drowsiness
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
How to use Resvom 5mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Resvom 5mg Tablet should be administered with a meal.
How Resvom 5mg Tablet works:
Resvom 5mg tablets counteract vestibular system overactivity, inhibiting the inner ear's vestibular apparatus via H1 receptor antagonism, thus alleviating vertigo. Its rapid onset, within 30 minutes, makes it ideal for acute vertigo episodes. Furthermore, its dopamine-blocking properties mitigate nausea and vomiting by interfering with dopamine's action in the brain's emetic center, providing antiemetic and antinauseant effects. Similarly, prochlorperazine's headache and anxiety-reducing effects are likely due to its antagonistic activity at both serotonin (5HT3) and dopamine (D2) receptors.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Resvom 5mg tablets and alcohol may result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Data on Resvom 5mg Tablet use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCAUTION
The use of Resvom 5mg Tablet while breastfeeding requires careful consideration. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the mother's system. Nevertheless, brief, infrequent use of Resvom 5mg Tablet to manage nausea and vomiting presents minimal danger to the nursing infant.
DrivingUNSAFE
Taking a Resvom 5mg Tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Resvom 5mg tablets. A modified dosage of Resvom 5mg tablets may be necessary. Physician consultation is recommended.
LiverCAUTION
Individuals with hepatic impairment should use Resvom 5mg tablets cautiously. Dosage modification of Resvom 5mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Resvom 5mg Tablet :
Should you forget a Resvom 5mg Tablet dose, take it immediately. If your next dose is nearly due, however, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Resvom 5mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Phenothiazine Derivative |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
